Arcosa, Inc.
No SEC Form 4 filings for $ACA in the last 30 days.
CRH plans to acquire Arcosa for about $8.5B, with closing expected in Q1 2027 subject to approvals. The deal would add about 35M tons of annual aggregates, targeting over 265M tons U.S. production, and add energy infrastructure exposure. CRH targets $175M annual cost synergies by year three and says the deal should be accretive within 12 months, but notes higher financing and integration risk.
Arcosa, Inc. (ACA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exh991earningsrelease63020.htm EX-99.1 Document Exhibit 99.1 News Release FOR IMMEDIATE RELEASE Arcosa, Inc. Announces Second Quarter 2026 Results DALLAS, Texas - ARCOSA, Inc. - August 5, 2026: Arcosa, Inc. (NYSE: ACA) (“Arcosa,” the “Company,” “We,” or “Our”), a provid
CRH said it will buy 100% of Arcosa in an all-cash deal for $150 per share, subject to Arcosa shareholder and regulatory approvals. The offer implies a 25% premium to Arcosa’s June 18 60-day VWAP. CRH values Arcosa at about $8.5B enterprise value (11.5x 2026E adj. EBITDA) and expects $175M annual synergies by year three.
Over the past 7 days, alphai's AI scored 1 news story mentioning ACA (Arcosa, Inc.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.
Recent ACA coverage spans mergers & acquisitions, market movers and financial news.
CRH plans to acquire Arcosa for about $8.5B, with closing expected in Q1 2027 subject to approvals. The deal would add about 35M tons of annual aggregates, targeting over 265M tons U.S. production, and add energy infrastructure exposure. CRH targets $175M annual cost synergies by year three and says the deal should be accretive within 12 months, but notes higher financing and integration risk.
Q2 operating performance was solid on EBITDA and backlog, but cash flow deteriorated sharply, and the CRH deal remains a key forward catalyst.
Arcosa’s stock is directly impacted by a fresh takeover offer, creating immediate deal-spread and takeover-probability trading.
ACA is tied to a potential M&A development; deal-rumor headlines can create high volatility and option-like trading behavior.
Deal speculation can drive sharp repricing, but headline risk remains until terms are confirmed.
alphai scores every news story that mentions ACA with an AI model for sentiment and relevance, and aggregates insider trades from Arcosa, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
CRH plans to acquire Arcosa for about $8.5B, with closing expected in Q1 2027 subject to approvals. The deal would add about 35M tons of annual aggregates, targeting over 265M tons U.S. production, and add energy infrastructure exposure. CRH targets $175M annual cost synergies by year three and says the deal should be accretive within 12 months, but notes higher financing and integration risk.
6 min readArcosa, Inc. (ACA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exh991earningsrelease63020.htm EX-99.1 Document Exhibit 99.1 News Release FOR IMMEDIATE RELEASE Arcosa, Inc. Announces Second Quarter 2026 Results DALLAS, Texas - ARCOSA, Inc. - August 5, 2026: Arcosa, Inc. (NYSE: ACA) (“Arcosa,” the “Company,” “We,” or “Our”), a provid
6 min readCRH said it will buy 100% of Arcosa in an all-cash deal for $150 per share, subject to Arcosa shareholder and regulatory approvals. The offer implies a 25% premium to Arcosa’s June 18 60-day VWAP. CRH values Arcosa at about $8.5B enterprise value (11.5x 2026E adj. EBITDA) and expects $175M annual synergies by year three.
3 min readUS stocks were mostly lower as megacap tech and software slid, with Palantir down over 6% and Oracle down over 4%. Alphabet fell more than 5% after DeepMind VP Jumper left for Anthropic. Treasury yields rose; 10-year yield ended at 4.507%. Markets priced a 39% chance of a 25 bp Fed hike on July 28–29.
6 min readUS stocks gave back early gains as software and defense shares fell. Alphabet dropped over 6% after Google DeepMind VP Jumper said to be leaving for Anthropic. Defense names slid after Iran said it made “major progress” with the US on a peace deal. Rates: 10-year Treasury yield rose to 4.489% amid $211B in auctions. Semiconductors and AI stocks led gains; Palantir, Intuit, Oracle fell, while SOXX hit a record.
7 min readU.S. stocks edged higher Monday: S&P 500 up ~0.21% to ~7,523, Dow ~0.42%, Nasdaq-100 ~0.53%. WTI fell ~0.7% to ~$75.30. Two all-cash deals led: AbbVie to buy Apogee Therapeutics for ~$10.9B and CRH to buy Arcosa for ~$8.5B. AI-memory stocks rose after SK Hynix overtook Samsung; Nebius and CoreWeave entered Nasdaq-100. Investors await May core PCE Thursday.
6 min readCRH plc agreed to acquire Arcosa, Inc. for $150 per share in cash, valuing Arcosa at about $8.5 billion and implying a 25% premium to its 60-day VWAP as of June 18, according to CRH. CRH expects $175 million in annual run-rate cost synergies by year three and accretion within 12 months after closing, targeted for Q1 2027.
3 min readThe newsletter highlights a muted start to the week, with S&P 500 flat and Nasdaq up, and WTI around $76.50. It covers SpaceX’s KeyBanc hold, AbbVie’s $10.9B purchase of Apogee, CRH’s $8.5B Arcosa deal, and analyst moves on Corning, Nucor, Estee Lauder, and semiconductor equipment. It also notes a 20-year Chevron-Microsoft natural gas power deal for a West Texas data center.
7 min readArcosa, Inc. (ACA) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-2.1 2 exh21mergeragreement.htm EX-2.1 Document EXHIBIT 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER by and among CRH AMERICAS, INC., NEON MERGER SUB, INC. and ARCOSA, INC. dated as of June 21, 2026 TABLE OF CONTENTS Page ARTICLE I CERTAIN DEFINITIONS 1 Section 1.1. Defin
4 min readAn insider at Arcosa, Inc. (ACA) has filed a Form 144 disclosing proposed sales of 1,408 and 5,429 Performance Shares, both dated May 15, 2025. The filing also reports a completed sale of 7,919 shares on April 8, 2026, for $884,648.12, with Morgan Stanley Smith Barney LLC identified as the broker. This is a routine administrative disclosure of intended and recent insider dispositions.
2 min read
